Efficacy Of Nivolumab Plus Ipilimumab In Primary Tumor As First-Line Therapy In The Patients With Advanced Renal Cell CarcinomaHiroshi Kikuchi,Takahiro Osawa,Ryuji Matsumoto,Takashige Abe,Satoru Maruyama,Toru Harabayashi,Haruka Miyata,Akira Kashiwagi,Ataru Sazawa,Riyo Fukui,Ken Morita,Ichiro Takeuchi,Noboru Yamashita,Keita Minami,Tango Mochizuki,Nobuo ShinoharaJOURNAL OF UROLOGY(2021)引用 3|浏览12暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要